Cancer Research UK Manchester Institute

20/11/2025

30/10/2025

Time is running out to apply to join us as a new Group Leader - applications close 2nd November, and we'd love to hear from you!



We encourage applicants from a broad range of scientific disciplines — including , , , , , and — to bring fresh perspectives and disruptive approaches to

We are looking for bold, innovative, and technically pioneering applications with the potential to transform our understanding of cancer biology and drive translational impact, in a position funded by Cancer Research UK

We particularly welcome applicants with expertise in the biology of solid cancers, tumour , cancer evolution, and computational or approaches to tumour ecosystems; but we encourage visionary proposals from across the spectrum of cancer research that complement and expand our existing strengths.

24/09/2025

New Group Leader Recruitment - apply now to join us at the Cancer Research UK Manchester Institute!

We are seeking to appoint exceptional early-career scientists & clinician scientists as Group Leaders to develop bold, innovative, and high-impact research programmes core funded by Cancer Research UK

Visit our website for full details: https://www.cruk.manchester.ac.uk/career/new-group-leader-recruitment-now-open-mi-25-54/ and see our video for an overview of this recruitment call from our Institute Director, Professor Samra Turajlić.

Situated within one of Europe’s largest and most dynamic cancer research ecosystems, we offer a unique opportunity to pursue cutting-edge discovery science and drive translation into clinical benefit. We are looking for visionary scientists ready to establish an independent, world-leading research programme and take full advantage of the extraordinary collaborative ecosystem across The University of Manchester, our partners in The Cancer Research UK National Biomarker Centre, and our clinical partners at The Christie NHS Foundation Trust

We particularly welcome applicants with expertise in the biology of solid cancers, tumour immunology, cancer evolution, and computational or machine learning approaches to tumour ecosystems; but we encourage visionary proposals from across the spectrum of cancer research that complement and expand our existing strengths.

We encourage applicants from a broad range of scientific disciplines — including molecular biology, mathematics, physics, computational biology, data science, and engineering — to bring fresh perspectives and disruptive approaches to cancer research.

We are looking for bold, innovative, and technically pioneering applications with the potential to transform our understanding of cancer biology and drive translational impact.

02/09/2025

Was great to see Stefan and Lachlan when they visited us in Manchester the other week - and fantastic to see their achievement in reaching the end of their marathon (in every sense of the word!) run!

Congratulations to Lambros Army for your achievements, and thank you for the money you've raised for Cancer Research UK

To find out more, and to add your support visit: https://lambrosarmy.com/

01/09/2025

Today we welcome Professor Samra Turajlić as our new Institute Director!

Professor Turajlić joins us Director of the Cancer Research UK Manchester Institute, as Consultant Medical Oncologist at The Christie NHS Foundation Trust, part of The University of Manchester and as Group Leader of the Cancer Dynamics research group.

Professor Turajlić’s work spans basic, translational and cancer research, and she has led numerous pioneering studies that have significantly advanced our understanding of cancer biology and treatment.

You can read more about her appointment on our website:

https://www.cruk.manchester.ac.uk/news/professor-samra-turajlic-appointed-as-institute-director/

Prof Turajlic is the Chief Investigator of translational studies into and cancer ( ), and her research goal is to develop an evolutionary understanding of hashtag for patient benefit. She is a member of the NCRI Bladder and Renal Cancer Clinical Studies Group, ESMO member for genitourinary cancers; and Scientific Committee member for ESMO, Molecular Analysis for Personalised Therapy, Kidney Cancer Association, and EORTC-NCI-AACR Symposia.

She is a Trustee of the Kidney Cancer Support Network and Melanoma Focus, and a Senior Editor at Macmillan Cancer Support. Prof Turajlić receives research funding from Cancer Research UK (CRUK), Rosetrees Trust, The Royal Marsden Cancer Charity, and the RMH/ICR Biomedical Research Centre, among others.

20/08/2025

We very much enjoyed our visit from the Lambros Army last week as they run (hard) across the UK to raise money for Cancer Research UK (and now they've added us to their fan page!)

Do check out their fundraising page: https://givestar.io/gs/lambros--project-uk-2025 as they keep running to raise money for

13/08/2025

Congratulations to Lambros Army who ran through today as part of their race to raise money for Cancer Research UK

They're running the entire UK in support of and they stopped off to see us at the Paterson Building today, running right through in the midst of a heatwave!

These two brothers from Australia are aiming to raise £250,000 by running 1000 miles, and on their fundraising page they say:

"We lost our beautiful grandma to cancer and our other grandma has battled ongoing treatment for cancer over the last decade. So our mission is to raise £250,000 for cancer research in 2025."

Visit their fundraising page for more on their amazing marathon running! - https://givestar.io/gs/lambros--project-uk-2025

21/07/2025

Congratulations to Dr Evangelos Giampazolias, head of our Cancer Immunosurveillence group, on receiving the British Association for Cancer Research (BACR)/AstraZeneca Young Scientist Frank Rose Award 2025!

The BACR/AstraZeneca Young Scientist Frank Rose Award has been given since 2005 to recognise and reward the achievements of an individual whose work has made significant contributions to translational cancer research, bringing findings from the laboratory into the clinic. Evangelos’ research has contributed to understanding the mechanisms underlying immune defence against cancer following host sensing of dying cells or signals derived from commensal microbes.

18/06/2025

We are delighted to announce, along with , and , the appointment of Professor Samra Turajlić as our new Institute Director!

For full details on this exciting announcement, please visit our website. Link in bio.

25/04/2025

We're over halfway to our fundraising total for today, thanks to many researchers at the Institute and the CRUK National Biomarker Centre wearing their football shirts in support of Cancer Research UK and Bobby Moore Fund for Cancer Research UK

We've even created our own customised football shirt for anyone who has forgotten their kit and still wants to take part!

If you'd like to find out more about the research that this fundraising supports, or if you'd like to support our fundraising efforts, you can find more details on our custom fundraising page:

https://fundraise.cancerresearchuk.org/page/cancer-research-uk-manchester-institute

21/03/2025

Interested in a new role in ? Find details of and technician positions we are currently recruiting for on the pages of our website:

https://www.cruk.manchester.ac.uk/careers/

You'll also find information on the benefits package we offer, more about Institute life and career development and training opportunities for staff

Find out more about the opportunities to join our research team - with roles in our core facilities, research groups, operations teams or as a PhD student